Trials / Conditions / Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
4 registered clinical trials studyying Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refr NCT04074746 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Withdrawn | Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma NCT04795869 | Northwestern University | Phase 2 |
| Active Not Recruiting | Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas NCT03598998 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Completed | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Periph NCT01590732 | M.D. Anderson Cancer Center | Phase 1 |